Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts General Hospital (MGH) Join Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial
Precision Biologics is pleased to announce the addition of Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts...